Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD
Status:
Completed
Trial end date:
2009-02-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is the evaluate the safety and tolerability of repeat dosing of the
combination of inhaled GSK233705 and GW642444 administered once-daily in subjects with COPD.